BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9558713)

  • 1. An unusual dienone-phenol rearrangement product formed during the synthesis of mometasone furoate (Sch 32088).
    Draper RW; Puar MS; Vater EJ; McPhail AT
    Steroids; 1998 Mar; 63(3):135-40. PubMed ID: 9558713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual rearrangement product formed during production of mometasone furoate (Sch 32088).
    Puar MS; Thompson PA; Ruggeri M; Beiner D; McPhail AT
    Steroids; 1995 Sep; 60(9):612-4. PubMed ID: 8545849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid state characterization of mometasone furoate anhydrous and monohydrate forms.
    Chen XS; Carillo M; Curtis Haltiwanger R; Bradley P
    J Pharm Sci; 2005 Nov; 94(11):2496-509. PubMed ID: 16200563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of degradation products of mometasone furoate.
    Sahasranaman S; Issar M; Tóth G; Horváth G; Hochhaus G
    Pharmazie; 2004 May; 59(5):367-73. PubMed ID: 15212303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A competitive enzyme immunoassay for the direct determination of mometasone furoate (SCH 32088) in human plasma.
    Wang CJ; Tian Z; Byrnes K; Lin CC
    J Pharm Biomed Anal; 1992 Jul; 10(7):473-9. PubMed ID: 1420471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced-fit docking of mometasone furoate and further evidence for glucocorticoid receptor 17alpha pocket flexibility.
    Wang H; Aslanian R; Madison VS
    J Mol Graph Model; 2008 Nov; 27(4):512-21. PubMed ID: 18986818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C.
    Ronchetti R; Pannone LA; Cerra B; Camaioni E; Lopopolo G; Attolino E; Gioiello A
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory activity of inhaled mometasone furoate in allergic mice.
    Chapman RW; Sehring SJ; Garlisi CG; Falcone A; Kung TT; Stelts D; Minnicozzi M; Jones H; Umland S; Egan RW; Kreutner W
    Arzneimittelforschung; 1998 Apr; 48(4):384-91. PubMed ID: 9608881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mometasone furoate].
    Veien NK
    Ugeskr Laeger; 1991 Sep; 153(40):2848-50. PubMed ID: 1926632
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding affinities of mometasone furoate and related compounds including its metabolites for the glucocorticoid receptor of rat skin tissue.
    Isogai M; Shimizu H; Esumi Y; Terasawa T; Okada T; Sugeno K
    J Steroid Biochem Mol Biol; 1993 Feb; 44(2):141-5. PubMed ID: 8439518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray.
    Meltzer EO; Jalowayski AA; Orgel HA; Harris AG
    J Allergy Clin Immunol; 1998 Jul; 102(1):39-49. PubMed ID: 9679846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active- and placebo-controlled study.
    Hebert JR; Nolop K; Lutsky BN
    Allergy; 1996 Aug; 51(8):569-76. PubMed ID: 8874661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
    Sharpe M; Jarvis B
    Drugs; 2001; 61(9):1325-50. PubMed ID: 11511026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate.
    Veien NK; Olholm Larsen P; Thestrup-Pedersen K; Schou G
    Br J Dermatol; 1999 May; 140(5):882-6. PubMed ID: 10354026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.
    Kecskés A; Heger-Mahn D; Kuhlmann RK; Lange L
    J Am Acad Dermatol; 1993 Oct; 29(4):576-80. PubMed ID: 8408793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children].
    Liu W; Chen RJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):366-368. PubMed ID: 29871263
    [No Abstract]   [Full Text] [Related]  

  • 17. Mometasone furoate.
    Am J Health Syst Pharm; 2001 Nov; 58(22):2140-1. PubMed ID: 11760915
    [No Abstract]   [Full Text] [Related]  

  • 18. Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment.
    Nissen JB; Avrach WW; Hansen ES; Stengaard-Pedersen K; Kragballe K
    Dermatology; 1999; 198(1):11-7. PubMed ID: 10026395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis.
    Minshall E; Ghaffar O; Cameron L; O'Brien F; Quinn H; Rowe-Jones J; Davies RJ; Prior A; Lund VJ; Mackay IS; Nolop K; Lutsky B; Durham SR; Hamid Q
    Otolaryngol Head Neck Surg; 1998 May; 118(5):648-54. PubMed ID: 9591864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes.
    Madauss KP; Deng SJ; Austin RJ; Lambert MH; McLay I; Pritchard J; Short SA; Stewart EL; Uings IJ; Williams SP
    J Med Chem; 2004 Jun; 47(13):3381-7. PubMed ID: 15189034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.